Main Market
North America
South America
Western Europe
Eastern Europe
Eastern Asia
Southeast Asia
Middle East
Africa
Oceania
Worldwide
Lumigenex, a high-tech enterprise founded by Dr. He. Lumigenex has independently developed nanotechnology with exclusive patent protection, combined with the world’s exclusive license patents obtained by the world’s top 500 Kimberly-Clark Cooperation, making Lumigenex have the world’s exclusive patent-protected time-resolved fluorescence detection technology The latest generation of real-time diagnostic immunoassay technology platform.
Main Market
North America
South America
Western Europe
Eastern Europe
Eastern Asia
Southeast Asia
Middle East
Africa
Oceania
Worldwide
Business Type
Manufacturer
Exporter
Seller
Brands : Lumigenex
No. of Employees : 100~150
Annual Sales : 10000000-20000000
Year Established : 2010
Export p.c : 80% - 90%